Methylphenidate Hydrochloride Tablet, Chewable
Product Images NDC 72865-125

9 FDA label images from Xlcare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72865-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Methylephenidate Structure)

Structure (Methylephenidate Structure)
Chemical structure of Methylphenidate Hydrochloride showing its molecular arrangement including a benzene ring, ester group, and piperidine ring with the hydrochloride component.*
FDA Label Image

Mg1 (Mg1)

Mg1 (Mg1)
This image shows a text panel containing safety warnings and precautions related to methylphenidate hydrochloride chewable tablets. It includes advice on monitoring for abuse and addiction risks, dependence concerns, proper storage, disposal instructions, and considerations for those with a history of substance abuse.*
FDA Label Image

Mg2 (Mg2)

Mg2 (Mg2)
This image shows a section of text from prescribing information or safety warnings for methylphenidate hydrochloride chewable tablets. It includes warnings about risks such as sudden death, stroke, heart attack, increased blood pressure and heart rate, and advises patients to inform healthcare providers of any heart problems. The text emphasizes regular monitoring of blood pressure and heart rate during treatment and instructs contacting a healthcare provider immediately if signs of heart problems occur.*
FDA Label Image

Mg3 (Mg3)

Mg3 (Mg3)
Text panel excerpt warning about new or worsening mental health symptoms and behavioral changes in patients taking methylphenidate hydrochloride chewable tablets, including hallucinations, mania, and suspicious thoughts. It advises immediate healthcare provider contact if such symptoms occur during treatment.*
FDA Label Image

Mg4 (Mg4)

Mg4 (Mg4)
A text panel containing safety warnings and precautions for methylphenidate hydrochloride chewable tablets, including instructions to inform healthcare providers about symptoms like numbness, pain, skin color changes, or sensitivity in fingers or toes, and to report any unexplained wounds appearing during treatment.*
FDA Label Image

Mg5 (Mg5)

Mg5 (Mg5)
A bullet-point list describing side effects or symptoms associated with the medication Methylphenidate Hydrochloride. The listed items include nervousness, trouble sleeping, headache, stomach ache, fast heart beat, nausea, decreased appetite, dizziness, and weight loss.*
FDA Label Image

Image Description (Methylphenidate Chewable 2.5 mg)

Image Description (Methylphenidate Chewable  2.5 mg)
The label for Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg strength, from XLCare Pharmaceuticals, Inc. It indicates an oral dosage form with 100 tablets per container. The label specifies prescription use only (Rx Only), includes a warning for phenylketonurics, and provides storage and handling instructions, including protection from moisture and controlled room temperature storage.*
FDA Label Image

Image Description (Methylphenidate Chewable 5 mg)

Image Description (Methylphenidate Chewable  5 mg)
Label for Methylphenidate Hydrochloride Chewable Tablets 5 mg by XLCare Pharmaceuticals, Inc. The oral chewable tablets come in a 100-count package. The label includes instructions for the pharmacist, storage conditions, and a warning for phenylketonurics that each tablet contains 0.70 mg phenylalanine. The NDC is 72865-126-01.*
FDA Label Image

Image Description (Methylphenidate Chewable 10 mg)

Image Description (Methylphenidate Chewable  10 mg)
Label for Methylphenidate Hydrochloride 10 mg chewable tablets by XLCare Pharmaceuticals, Inc. The label indicates 100 tablets per bottle, with directions to dispense the Medication Guide separately. Storage instructions and caution to protect from moisture are included. Manufactured by Ascent Pharmaceuticals, Inc., with lot and expiration fields present but not filled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.